These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


462 related items for PubMed ID: 25963141

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
    Jiao Y, Cai S, Lin J, Zhu W, Xi J, Li J, Yue D, Zhang T, Qiao K, Wang Y, Zhao C, Lu J.
    J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
    [Abstract] [Full Text] [Related]

  • 5. Clinical and histological findings associated with autoantibodies detected by RNA immunoprecipitation in inflammatory myopathies.
    Suzuki S, Yonekawa T, Kuwana M, Hayashi YK, Okazaki Y, Kawaguchi Y, Suzuki N, Nishino I.
    J Neuroimmunol; 2014 Sep 15; 274(1-2):202-8. PubMed ID: 25064497
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.
    Pinal-Fernandez I, Parks C, Werner JL, Albayda J, Paik J, Danoff SK, Casciola-Rosen L, Christopher-Stine L, Mammen AL.
    Arthritis Care Res (Hoboken); 2017 Feb 15; 69(2):263-270. PubMed ID: 27111848
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Necrotising myopathy associated with anti-signal recognition particle (anti-SRP) antibody.
    De Souza FHC, Miossi R, Shinjo SK.
    Clin Exp Rheumatol; 2017 Feb 15; 35(5):766-771. PubMed ID: 28281460
    [Abstract] [Full Text] [Related]

  • 14. Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome.
    Suzuki S, Hayashi YK, Kuwana M, Tsuburaya R, Suzuki N, Nishino I.
    Arch Neurol; 2012 Jun 15; 69(6):728-32. PubMed ID: 22332183
    [Abstract] [Full Text] [Related]

  • 15. Myopathy with anti-signal recognition particle antibodies: clinical and histopathological features in Chinese patients.
    Wang L, Liu L, Hao H, Gao F, Liu X, Wang Z, Zhang W, Lv H, Yuan Y.
    Neuromuscul Disord; 2014 Apr 15; 24(4):335-41. PubMed ID: 24491486
    [Abstract] [Full Text] [Related]

  • 16. Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy.
    Anquetil C, Boyer O, Wesner N, Benveniste O, Allenbach Y.
    Autoimmun Rev; 2019 Mar 15; 18(3):223-230. PubMed ID: 30639649
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A pediatric patient with myopathy associated with antibodies to a signal recognition particle.
    Kawabata T, Komaki H, Saito T, Saito Y, Nakagawa E, Sugai K, Sasaki M, Hayashi YK, Nishino I, Momomura M, Kizawa T, Imagawa T, Yokota S.
    Brain Dev; 2012 Nov 15; 34(10):877-80. PubMed ID: 22436377
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [A case of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody-positive paraneoplastic necrotizing myopathy associated with advanced gastric cancer that responded to intravenous immunoglobulin therapy].
    Yamaguchi T, Matsunaga A, Ikawa M, Shirafuji N, Nishino I, Hamano T.
    Rinsho Shinkeigaku; 2017 Mar 28; 57(3):118-123. PubMed ID: 28228619
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.